- Home
- HROW vs ESTA Comparison
HROW vs ESTA Comparison
Compare HROW & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- ESTA
- Stock Information
- Founded
- HROW 1998
- ESTA 2004
- Country
- HROW United States
- ESTA Costa Rica
- Employees
- HROW 382
- ESTA N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- ESTA Industrial Specialties
- Sector
- HROW Health Care
- ESTA Health Care
- Exchange
- HROW Nasdaq
- ESTA Nasdaq
- Market Cap
- HROW 1.4B
- ESTA 1.3B
- IPO Year
- HROW N/A
- ESTA 2018
- Fundamental
- Price
- HROW $39.22
- ESTA $42.49
- Analyst Decision
- HROW Strong Buy
- ESTA Strong Buy
- Analyst Count
- HROW 7
- ESTA 6
- Target Price
- HROW $64.67
- ESTA $57.00
- AVG Volume (30 Days)
- HROW 671.7K
- ESTA 483.0K
- Earning Date
- HROW 08-11-2025
- ESTA 08-07-2025
- Dividend Yield
- HROW N/A
- ESTA N/A
- EPS Growth
- HROW N/A
- ESTA N/A
- EPS
- HROW N/A
- ESTA N/A
- Revenue
- HROW $227,661,000.00
- ESTA $177,418,000.00
- Revenue This Year
- HROW $46.17
- ESTA $28.32
- Revenue Next Year
- HROW $39.97
- ESTA $24.16
- P/E Ratio
- HROW N/A
- ESTA N/A
- Revenue Growth
- HROW 47.69
- ESTA 17.22
- 52 Week Low
- HROW $20.85
- ESTA $26.56
- 52 Week High
- HROW $59.23
- ESTA $50.85
- Technical
- Relative Strength Index (RSI)
- HROW 62.35
- ESTA 56.37
- Support Level
- HROW $37.09
- ESTA $40.47
- Resistance Level
- HROW $39.67
- ESTA $42.79
- Average True Range (ATR)
- HROW 2.41
- ESTA 2.25
- MACD
- HROW 0.10
- ESTA 0.61
- Stochastic Oscillator
- HROW 87.23
- ESTA 88.35
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.